Shanghai Kaibao Pharmaceutical Co. Ltd. | |
Stock Exchange | Shenzhen Stock Exchange |
EPS |
CNY0.19 |
Market Cap |
CNY4.79 B |
Shares Outstanding |
801.47 M |
Public Float |
689.19 M |
Address |
No. 88, Chengpu Road Shanghai Shanghai 201401 China |
Employees | - |
Website | http://www.xykb.com |
Updated | 07/08/2019 |
Shanghai Kaibao Pharmaceutical Co., Ltd. engages in the research, development, manufacture and sale of modern Chinese medicine. Its medicines are in the form of injection, tablets, hard capsules, granules, mixture, syrup, oral liquid, and Chinese medicine extraction; such as Tanreqing injection, doxofylline capsule, Captopril sustained-release tablets, and Hydrochloride pioglitazone tablets. The company was founded on April 12, 2000 and is headquartered in Shanghai, China. |